Javara: growth investment funding
Integrated research organization Javara has landed a significant growth investment in a Series B funding round led by equity firm General Atlantic. Javara is one of the forefront voices in the clinical research as a care option movement.
“We founded Javara with a vision to transform clinical research delivery, creating a business and technology framework whereby clinical trials are on the menu of care options for all patients within the entire healthcare system,” said Javara CEO Jennifer Byrne. “Our focus in pioneering this innovative approach was – and remains – to create a model that drives value across the industry for all stakeholders, while ensuring all patients have the access to the care they deserve.”